Ontrak (NASDAQ:OTRK) & NewGenIvf Group (NASDAQ:NIVF) Critical Review

Ontrak (NASDAQ:OTRK) and NewGenIvf Group (NASDAQ:NIVF) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, analyst recommendations, valuation and dividends.

Earnings & Valuation

This table compares Ontrak and NewGenIvf Group”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ontrak	$12.39 million	10.19	-$27.92 million	($4.00)	-0.66
NewGenIvf Group	$5.14 million	0.45	$130,000.00	N/A	N/A

NewGenIvf Group has lower revenue, but higher earnings than Ontrak.

Institutional & Insider Ownership

12.9% of Ontrak shares are held by institutional investors. Comparatively, 66.2% of NewGenIvf Group shares are held by institutional investors. 1.6% of Ontrak shares are held by company insiders. Comparatively, 31.8% of NewGenIvf Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Analyst Recommendations

This is a summary of current recommendations and price targets for Ontrak and NewGenIvf Group, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ontrak	0	0	2	0	3.00
NewGenIvf Group	0	0	0	0	N/A

Ontrak currently has a consensus price target of $3.00, indicating a potential upside of 14.07%. Given Ontrak’s higher probable upside, analysts plainly believe Ontrak is more favorable than NewGenIvf Group.

Profitability

This table compares Ontrak and NewGenIvf Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Ontrak	-222.54%	-238.43%	-119.20%
NewGenIvf Group	N/A	N/A	N/A

Volatility and Risk

Ontrak has a beta of 2.58, meaning that its stock price is 158% more volatile than the S&P 500. Comparatively, NewGenIvf Group has a beta of 0.29, meaning that its stock price is 71% less volatile than the S&P 500.

Summary

NewGenIvf Group beats Ontrak on 6 of the 11 factors compared between the two stocks.

About Ontrak

Ontrak, Inc. operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to third-party payors in the United States. Its technology-enabled platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care they need. The company's technology enabled OnTrak program provides healthcare solutions to members with behavioral conditions that cause or exacerbate chronic medical conditions, such as diabetes, hypertension, coronary artery disease, chronic obstructive pulmonary disease, and congestive heart failure. The OnTrak integrates evidence-based psychosocial and medical interventions delivered in-person or via telehealth along with care coaching and in-market community care coordinators, who address the social and environmental determinants of health. The company was formerly known as Catasys, Inc. and changed its name to Ontrak, Inc. in July 2020. Ontrak, Inc. was incorporated in 2003 and is headquartered in Miami, Florida.

About NewGenIvf Group

A SPAC I Acquisition Corp. is a blank check company. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or related business combination with one or more businesses. A SPAC I Acquisition Corp. is based in Singapore.